Business Wire

World First at Maria Middelares Hospital in Belgium Thanks to da Vinci SP’s Innovative Technology

29.5.2024 15:37:00 EEST | Business Wire | Press release

Share

As part of the new Health Value Space Ghent, Maria Middelares Hospital continues to lead the way as a “smart” hospital, poised to deliver healthcare of the future to its patients. The new da Vinci SP (single port) surgical system has now been in use since May 21, making complex surgery even less invasive, via a single incision. It was on May 27 that a world first took place at the hospital: a kidney autotransplantation assisted by the da Vinci SP surgical system.

The arrival of Intuitive’s new da Vinci SP system aligns perfectly with Maria Middelares' vision of developing a patient-oriented robotics platform. The SP enables more complex procedures to be performed through a single incision or natural orifice. Over 400 peer-reviewed publications demonstrate the safety, efficacy, and excellent results of this cutting-edge technology. The da Vinci SP offers incredible value on a daily basis for Maria Middelares and its patients.

  • A World First

On May 27, urologist Prof. dr. Decaestecker achieved a world first. Using the da Vinci SP, he performed an intracorporeal kidney autotransplantation on an 18-year-old woman suffering from a complex ureteral lesion, with severe damage to the ureter between the kidney and the bladder. The best solution for the patient was to bridge the major defect in the ureter by moving the kidney closer to the bladder. This technique is called autotransplantation.

The transplantation was achieved intracorporeally, meaning entirely inside the body. Prof. dr. Decaestecker has perfected this technique, having performed such operations since 2017 (a European first at the time) using the da Vinci Multiport system, equipped with four robotic arms. The advantage of an in-body operation is that no large incisions are required to move the kidney in and out of the body; only a few small incisions (with the Multiport) of around 1 cm were needed to introduce the robotic instruments.

Prof. dr. Decaestecker explains: What’s new now is the combination of in-body grafting with a single incision thanks to the SP robotic system, which has just one articulated arm. This is less intrusive for the patient’s body and should also facilitate smoother post-op recovery. Other advantages are that we can perform the procedure entirely outside the abdomen, allowing the patient to lie flat on their back in a natural position. This is important as the patient can now be operated on in a more comfortable position, therefore with fewer intestinal complications.”

  • What does the future hold?

With the development of a robotics platform, Maria Middelares aims to optimize the use of robotic systems within the operating room as much as possible. The goal is to improve operating room efficiency and patient outcomes. These innovative surgical systems allow for further personalization of surgery based on patient needs.

Dr. Ameye, Director of Innovation, adds: “In our organization, we strive to seek out the best technology combined with in-depth monitoring. We map the quality of care using big data analysis based on a multitude of uniform data. This enables us to identify areas for improvement and continuously optimize our care. Providing value-based healthcare is our main motivation.”

You can download images from the operating room of this world premiere via this link.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For further information

Catherine Zenner, Head of Communications Maria Middelares
catherine.zenner@mijnziekenhuis.be or 0478 99 53 11.

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody18.6.2026 02:01:00 EEST | Press release

LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise therapeutic antibodies, today announced a multi-year research collaboration, option and licensing agreement with LG Chem. The collaboration aims to identify next-generation multispecific antibodies designed to overcome the key limitations of existing immunotherapies, including on-target, off-tumour toxicities. Together, the companies will aim to develop a novel, tumour-selective therapeutic targeting a solid tumour antigen expressed across multiple difficult-to-treat cancer types. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615992992/en/ “Partnering with LG Chem represents a very important moment for LabGenius and provides further validation of our platform’s ability to design highly optimised multispecific antibodies,”said Dr. James Field, CEO of LabGenius. “We welcome this opp

Joe Vernachio Named President of SOREL18.6.2026 01:00:00 EEST | Press release

Columbia Sportswear Company (Nasdaq: COLM), a leading innovator in active outdoor apparel, footwear, accessories and equipment, today announced that Joe Vernachio will be the next President of SOREL. Founded in 1962, SOREL is a leader in functional and lifestyle footwear that can be worn anywhere from the tundra to the streets of New York City. “We’re excited to welcome Joe Vernachio back to the Columbia Sportswear family,” said Tim Boyle, CEO and Chair of the Board. “Joe is a terrific leader who can build on the great work, talent and momentum in place at SOREL.” Mr. Vernachio led the Mountain Hardwear brand for several years, until he left to become the COO and ultimately, the CEO of Allbirds. His background also includes time as Global Vice President for Product and Operations at The North Face, and key roles at Nike, Spyder, Roots, Calvin Klein and Patagonia. “Joe is a consumer‑focused, collaborative leader with a deep passion for product and brand storytelling. His energy, experti

Venture Global and EnBW Announce New LNG Purchase Agreements17.6.2026 23:30:00 EEST | Press release

Today, Venture Global, Inc. (NYSE: VG) and EnBW announced the execution of new, binding agreements for the purchase of approximately 0.82 million tonnes per annum (MTPA) of U.S. liquefied natural gas (LNG) from Venture Global for approximately five years commencing in 2026, to be supplied from Venture Global’s portfolio. The new agreements add to the existing long-term sales and purchase agreements (SPAs) between Venture Global and EnBW for 2 MTPA for 20 years. “As one of Germany’s top LNG suppliers, Venture Global is proud to strengthen our partnership with EnBW and support the region’s energy security with a reliable supply of LNG,” said Venture Global CEO Mike Sabel. “The new mid-term agreements build on our strong, long-standing relationship with EnBW and reflects our commitment to meeting our customers’ evolving energy needs. Our dynamic marketing platform uniquely positions us to provide supply solutions across the short, medium, and long term.” About Venture Global Venture Globa

Kinaxis Announces Results of Voting at Annual and Special Meeting of Shareholders17.6.2026 23:05:00 EEST | Press release

Kinaxis® Inc. (“Kinaxis” or the “Company”) (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, received approval for all resolutions put forward to shareholders at today’s Annual and Special Meeting of Shareholders (the “Meeting”), as detailed in the Company’s management information circular dated May 5, 2026 (the “Circular”). 1. Election of Directors Shareholders voted to elect all eight directors nominated to the Kinaxis board, to hold office until the close of the next annual meeting of shareholders of the Company or until their successors are elected or appointed. Name of Nominee Total Number of Votes For Percentage of Votes For Total Number of Votes Against Percentage of Votes Against Razat Gaurav 21,870,163 99.01% 219,468 0.99% Robert Courteau 20,882,945 94.54% 1,206,685 5.46% Gillian (Jill) Denham 21,474,486 97.22% 615,143 2.78% José Alberto Duarte 21,699,181 98.23% 390,448 1.77% Lynn Loewen 21,952,244 99.38% 137,387 0.62% Angel Mendez 21,410,402 96

SES Announces Results of the Extraordinary General Meeting of Shareholders17.6.2026 20:23:00 EEST | Press release

SES (the “Company”) held an Extraordinary General Meeting (“EGM”) of Shareholders today in Betzdorf, Luxembourg. Following the recommendations made by the Board of Directors of SES, the shareholders have voted in favor of all resolutions. In particular, shareholders approved the cancellation of shares repurchased under the Company’s share buyback program of 2 November 2023, as amended on 2 May 2024, resulting in a corresponding reduction of the Company’s share capital. Shareholders also approved amendments to the Company’s articles of association, including indemnification for Board members and executives, as well as updates relating to the conduct of shareholder meetings. Detailed results on all matters voted on at the EGM will be available on the company’s webpage: https://www.ses.com/company/investors/shareholder-information/general-meeting-shareholders Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we b

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye